TJ

Thale Jarvis

SO Somalogic: 8 patents #10 of 84Top 15%
RP Ribozyme Pharmaceuticals: 6 patents #14 of 62Top 25%
CR Crestone: 3 patents #5 of 13Top 40%
ST Sirna Therapeutics: 1 patents #87 of 124Top 75%
BS Biovector Therapeutics, S.A.: 1 patents #10 of 31Top 35%
UC University of Colorado: 1 patents #288 of 930Top 35%
OC Otsuka Pharmaceutical Co.: 1 patents #681 of 1,273Top 55%
RE Replidyne: 1 patents #11 of 22Top 50%
Overall (All Time): #193,209 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11655225 Antimycobacterial heterocyclic amides Joshua Day, James Graham, Elizabeth A. McFaddin, Urs Ochsner, Xicheng Sun +1 more 2023-05-23
11221340 Lung cancer biomarkers and uses thereof Sheri K. Wilcox, Deborah Ayers, Nebojsa Janjic, Larry Gold, Michael Riel-Mehan 2022-01-11
11208663 Post-selex modification methods John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more 2021-12-28
10221421 Post-selec modification methods John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more 2019-03-05
9701967 Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more 2017-07-11
9410156 Aptamers to PDGF and VEGF and their use in treating PDGF and VEGF mediated conditions John C. Rohloff, Amy D. Gelinas, Chi Zhang, Daniel W. Drolet, Sheela M. Waugh +1 more 2016-08-09
9382533 Method for generating aptamers with improved off-rates Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton +2 more 2016-07-05
9206429 Aptamers that bind to IL-6 and their use in treating or diagnosing IL-6 mediated conditions Shashi Gupta, Masao Hirota, Daniel J. Schneider, Tomoki Suzuki, Yuichi Ishikawa +4 more 2015-12-08
8975026 Method for generating aptamers with improved off-rates Dominic Zichi, Sheri K. Wilcox, Chris Bock, Daniel J. Schneider, Bruce Eaton +2 more 2015-03-10
8716320 Antibacteriall heterocyclic ureas Joseph Guiles, Sarah Strong, Xicheng Sun 2014-05-06
8431376 Bacterial replication systems and methods Charles S. McHenry, Nebojsa Janjic, Garry Dallmann, James M. Bullard, Stacie Bell +2 more 2013-04-30
8293919 Antibacterial sulfone and sulfoxide substituted heterocyclic urea compounds Joseph Guiles, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff 2012-10-23
8148380 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds Joseph Guiles, Sarah Strong, Xicheng Sun, Jian Qiu, John C. Rohloff 2012-04-03
6673611 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression James D. Thompson, Leonid Beigelman, James McSwiggen, Alexander Karpeisky, Laurent Bellon +5 more 2004-01-06
6586238 Enzymatic nucleic acids containing 5′-and or 3′-cap structures Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Nassim Usman, Anthony DiRenzo +1 more 2003-07-01
6214621 Conjugates of a particle vector and oligonucleotides, process for their preparation, and pharmaceutical compositions containing them Didier Betbeder, Roger Kravtzoff, Ignacio De Miguel, Sophie Sixou, Pamela Pavco 2001-04-10
6194150 Nucleic acid based inhibition of CD40 Dan T. Stinchcomb, James McSwiggen 2001-02-27
6103890 Enzymatic nucleic acids that cleave C-fos James McSwiggen, Dan T. Stinchcomb 2000-08-15
5998203 Enzymatic nucleic acids containing 5'-and/or 3'-cap structures Jasenka Matulic-Adamic, Leonid Beigelman, Alexander Karpeisky, Nassim Usman, Anthony DiRenzo +1 more 1999-12-07
5877021 B7-1 targeted ribozymes Dan T. Stinchcomb, James McSwiggen 1999-03-02
5817796 C-myb ribozymes having 2'-5'-linked adenylate residues Dan T. Stinchcomb, Kenneth G. Draper, James McSwiggen 1998-10-06
5646042 C-myb targeted ribozymes Dan T. Stinchcomb, Kenneth G. Draper, James McSwiggen 1997-07-08